{"predictions": [[{"text": "NG-nitro-L-arginine", "identifier": "D019335"}, {"text": "nitric-oxide synthase", "identifier": "D019001"}, {"text": "nitric oxide", "identifier": "D020030"}, {"text": "haloperidol", "identifier": "D006220"}, {"text": "catalepsy", "identifier": "D002375"}, {"text": "NG-nitro-L-arginine", "identifier": "D019335"}, {"text": "sub-chronic", "identifier": "D004961"}, {"text": "L-NOARG", "identifier": "D004961"}, {"text": "nitric-oxide", "identifier": "D019001"}], [{"text": "doxorubicin", "identifier": "D004317"}, {"text": "cardiotoxicity", "identifier": "D066126"}, {"text": "rat model", "identifier": "D017941"}, {"text": "cardiac magnetic resonance imaging", "identifier": "D019028"}, {"text": "Hannover Wistar rats", "identifier": "D017208"}, {"text": "doxorubicin", "identifier": "D004317"}, {"text": "subcellular degeneration", "identifier": "D013347"}, {"text": "mitochondrial changes", "identifier": "D001832"}, {"text": "cardiomyocyte degeneration", "identifier": "D009410"}, {"text": "hypertrophy", "identifier": "D006984"}], [{"text": "Levodopa", "identifier": "D007980"}, {"text": "Parkinson's disease", "identifier": "D010300"}, {"text": "dyskinesia", "identifier": "D004409"}, {"text": "multiethnic Malaysians", "identifier": "D004961"}, {"text": "chronic pulsatile levodopa therapy", "identifier": "D011673"}, {"text": "motor fluctuations", "identifier": "D009045"}, {"text": "UPDRS questionnaires", "identifier": "D011795"}, {"text": "predictors of dyskinesia", "identifier": "D004409"}, {"text": "cross-sectional study", "identifier": "D019412"}, {"text": "patients with PD", "identifier": "D010361"}, {"text": "uninterrupted levodopa therapy", "identifier": "D007980"}], [{"text": "ethambutol", "identifier": "D004977"}, {"text": "optic neuropathy", "identifier": "D018917"}, {"text": "tuberculosis", "identifier": "D018088"}, {"text": "lung", "identifier": "D016040"}, {"text": "lymph node", "identifier": "D008197"}, {"text": "Siriraj Hospital", "identifier": "D006754"}, {"text": "clinical characteristics", "identifier": "D040821"}, {"text": "visual outcome", "identifier": "D000079602"}, {"text": "visual acuity", "identifier": "D014792"}, {"text": "initial visual acuity", "identifier": "D014792"}, {"text": "final visual acuity", "identifier": "D014792"}], [{"text": "Tetracycline", "identifier": "D013753"}, {"text": "rat", "identifier": "D017941"}, {"text": "fatty liver", "identifier": "D005235"}, {"text": "dose-response relationships", "identifier": "D004306"}, {"text": "hepatic accumulation of triglyceride", "identifier": "D000067552"}, {"text": "oleic acid", "identifier": "D019301"}, {"text": "intact rat", "identifier": "D017941"}, {"text": "isolated perfused liver", "identifier": "D000067268"}, {"text": "male rat", "identifier": "D017941"}, {"text": "female rat", "identifier": "D017941"}], [{"text": "tobramycin", "identifier": "D014031"}, {"text": "carbenicillin", "identifier": "D002228"}, {"text": "neutropenia", "identifier": "D009503"}, {"text": "cancer patients", "identifier": "D010361"}, {"text": "myelosuppressive chemotherapy", "identifier": "D060828"}, {"text": "infections", "identifier": "D017250"}, {"text": "cure rate", "identifier": "D001723"}, {"text": "pneumonia", "identifier": "D000077299"}, {"text": "gram-negative bacilli", "identifier": "D016905"}, {"text": "Klebsiella pneumoniae", "identifier": "D007711"}], [{"text": "cocaine", "identifier": "D003042"}, {"text": "recreational cocaine users", "identifier": "D003042"}, {"text": "facial expression recognition", "identifier": "D005149"}, {"text": "emotional facial expression", "identifier": "D005149"}, {"text": "happiness", "identifier": "D006240"}, {"text": "surprise", "identifier": "D004961"}, {"text": "sadness", "identifier": "D000078602"}, {"text": "anger", "identifier": "D000786"}, {"text": "fear", "identifier": "D005239"}, {"text": "disgust", "identifier": "D000078382"}, {"text": "psychopathology", "identifier": "D011599"}], [{"text": "Metronidazole", "identifier": "D008795"}, {"text": "encephalopathy", "identifier": "D000070627"}, {"text": "neurological complications", "identifier": "D048909"}, {"text": "metronidazole", "identifier": "D008795"}, {"text": "prolonged metronidazole intake", "identifier": "D008795"}, {"text": "MRI", "identifier": "D038524"}, {"text": "brain", "identifier": "D001930"}, {"text": "dentate nuclei", "identifier": "D002529"}, {"text": "cerebellum", "identifier": "D002531"}, {"text": "splenium", "identifier": "D004961"}], [{"text": "Parkinson's disease", "identifier": "D010300"}, {"text": "subthalamic nucleus", "identifier": "D020531"}, {"text": "high frequency stimulation", "identifier": "D006612"}, {"text": "advanced Parkinson's disease", "identifier": "D010300"}, {"text": "Hoehn and Yahr scale", "identifier": "D010054"}, {"text": "bradykinesia", "identifier": "D018476"}, {"text": "rigidity", "identifier": "D009127"}, {"text": "levodopa-induced dyskinesias", "identifier": "D020820"}, {"text": "Unified Parkinson's Disease Rating Scale", "identifier": "D010300"}], [{"text": "All-trans retinoic acid", "identifier": "D018168"}, {"text": "acute promyelocytic leukemia", "identifier": "D015473"}, {"text": "APL", "identifier": "D006163"}, {"text": "myositis", "identifier": "D055622"}, {"text": "inflammatory myositis", "identifier": "D009220"}, {"text": "skeletal muscle involvement", "identifier": "D024744"}, {"text": "adverse effects", "identifier": "D000069451"}, {"text": "rare", "identifier": "D011904"}, {"text": "children", "identifier": "D019988"}, {"text": "recognition", "identifier": "D021641"}], [{"text": "Graves' disease", "identifier": "D006111"}, {"text": "propylthiouracil", "identifier": "D011441"}, {"text": "MPO-ANCA", "identifier": "D004961"}, {"text": "vasculitis", "identifier": "D031300"}, {"text": "Graves' disease patients", "identifier": "D006111"}, {"text": "PTU", "identifier": "D004961"}, {"text": "MPO-ANCA-positive vasculitis", "identifier": "D031300"}, {"text": "hyperthyroidism", "identifier": "D006980"}, {"text": "clinical manifestations", "identifier": "D012877"}, {"text": "appearance", "identifier": "D000067029"}], [{"text": "Alendronate", "identifier": "D019386"}, {"text": "osteoporosis", "identifier": "D010024"}, {"text": "bone resorption", "identifier": "D001862"}, {"text": "bisphosphonates", "identifier": "D004164"}, {"text": "alendronate", "identifier": "D019386"}, {"text": "biphosphonate", "identifier": "D004002"}, {"text": "postmenopausal women", "identifier": "D015663"}, {"text": "side effects", "identifier": "D065606"}, {"text": "gastrointestinal", "identifier": "D005770"}, {"text": "musculoskeletal pain", "identifier": "D059352"}], [{"text": "Adriamycin", "identifier": "D004317"}, {"text": "spontaneously hypertensive rats", "identifier": "D011918"}, {"text": "losartan", "identifier": "D019808"}, {"text": "angiotensin II type-1 receptor blocker", "identifier": "D057911"}, {"text": "ADR nephropathy", "identifier": "D001449"}, {"text": "glomerulosclerosis", "identifier": "D003928"}, {"text": "proteinuria", "identifier": "D011507"}, {"text": "tubular atrophy", "identifier": "D000141"}, {"text": "interstitial fibrosis", "identifier": "D011658"}], [{"text": "Arginine vasopressin (AVP)", "identifier": "D001127"}, {"text": "Atrial natriuretic peptide (ANP)", "identifier": "D009320"}, {"text": "arterial blood pressure (MAP)", "identifier": "D062186"}, {"text": "heart rate (HR)", "identifier": "D006340"}, {"text": "normotensive rats (WKY)", "identifier": "D011921"}, {"text": "spontaneously hypertensive rats (SHR)", "identifier": "D011918"}, {"text": "arginine vasopressin", "identifier": "D001127"}, {"text": "atrial natriuretic peptide", "identifier": "D017461"}], [{"text": "Quetiapine", "identifier": "D000069348"}, {"text": "schizo-affective disorder", "identifier": "D001883"}, {"text": "first-generation antipsychotics", "identifier": "D014150"}, {"text": "zuclopenthixol", "identifier": "D003006"}, {"text": "lithium", "identifier": "D008094"}, {"text": "serum lithium", "identifier": "D008094"}, {"text": "agitation", "identifier": "D011595"}, {"text": "environmental explanation", "identifier": "D018876"}, {"text": "manic shift", "identifier": "D000073577"}, {"text": "akathisia", "identifier": "D017109"}], [{"text": "disseminated necrotizing leukoencephalopathy", "identifier": "D004211"}, {"text": "acute lymphoblastic leukemia", "identifier": "D054198"}, {"text": "high-dose methotrexate", "identifier": "D008727"}, {"text": "magnetic resonance images", "identifier": "D049448"}, {"text": "white matter", "identifier": "D066127"}, {"text": "contrast enhancement", "identifier": "D024803"}, {"text": "necrosis", "identifier": "D009336"}, {"text": "myelination", "identifier": "D004961"}, {"text": "leukoencephalopathy", "identifier": "D054038"}], [{"text": "pilocarpine", "identifier": "D010862"}, {"text": "temporal lobe epilepsy", "identifier": "D004833"}, {"text": "neuropathological sequelae", "identifier": "D004961"}, {"text": "gamma-aminobutyric acid (GABA)", "identifier": "D005680"}, {"text": "substantia nigra", "identifier": "D013378"}, {"text": "L-glutamic acid decarboxylase", "identifier": "D065105"}, {"text": "isoniazid", "identifier": "D007538"}, {"text": "SNR", "identifier": "D004961"}, {"text": "non-convulsant doses", "identifier": "D004961"}], [{"text": "Methamphetamine", "identifier": "D008694"}, {"text": "neurotoxic dose", "identifier": "D019583"}, {"text": "long-lasting depressive-like behaviour", "identifier": "D020746"}, {"text": "monoaminergic system", "identifier": "D004064"}, {"text": "methamphetamine", "identifier": "D008694"}, {"text": "disruption", "identifier": "D061185"}, {"text": "depressive symptoms", "identifier": "D003863"}, {"text": "drug withdrawal", "identifier": "D013375"}, {"text": "swimming speed", "identifier": "D013550"}, {"text": "escape latency", "identifier": "D004924"}], [{"text": "postoperative delirium", "identifier": "D003693"}, {"text": "population", "identifier": "D011153"}, {"text": "risk factors", "identifier": "D012307"}, {"text": "ICU", "identifier": "D007363"}, {"text": "elective major surgery", "identifier": "D017558"}, {"text": "confusion assessment method", "identifier": "D003221"}, {"text": "early postoperative delirium", "identifier": "D003693"}, {"text": "prevalence", "identifier": "D015995"}, {"text": "anesthetic drugs", "identifier": "D000777"}, {"text": "thiopentone", "identifier": "D013874"}, {"text": "propofol", "identifier": "D000072736"}], [{"text": "ecstasy", "identifier": "D018817"}, {"text": "dysfunctional overnight memory consolidation", "identifier": "D000069077"}, {"text": "memory consolidation", "identifier": "D000069077"}, {"text": "regular ecstasy users", "identifier": "D055030"}, {"text": "drug naive", "identifier": "D004342"}, {"text": "healthy controls", "identifier": "D000070497"}, {"text": "word pairs", "identifier": "D015443"}, {"text": "sleep", "identifier": "D012895"}, {"text": "neurocognitive impairments", "identifier": "D060825"}, {"text": "associative interference", "identifier": "D018886"}, {"text": "frontostriatal neural circuitry", "identifier": "D009432"}], [{"text": "Dobutamine", "identifier": "D004280"}, {"text": "dobutamine stress echocardiography", "identifier": "D025401"}, {"text": "cocaine", "identifier": "D003042"}, {"text": "chest pain", "identifier": "D002637"}, {"text": "STEMI", "identifier": "D000072657"}, {"text": "ECG", "identifier": "D004562"}, {"text": "tropinin I", "identifier": "D044062"}, {"text": "intensive diagnostic and treatment unit", "identifier": "D019937"}, {"text": "intensive care unit", "identifier": "D003422"}], [{"text": "antithrombotic drug", "identifier": "D004342"}, {"text": "cerebral microbleeds", "identifier": "D002533"}, {"text": "intracerebral hemorrhage", "identifier": "D002543"}, {"text": "ischemic stroke", "identifier": "D019194"}, {"text": "transient ischemic attack", "identifier": "D002546"}, {"text": "odds ratio", "identifier": "D016017"}, {"text": "cohorts", "identifier": "D004961"}, {"text": "follow-up studies", "identifier": "D005500"}, {"text": "stroke", "identifier": "D000071939"}, {"text": "hemorrhage", "identifier": "D002543"}], [{"text": "suxamethonium", "identifier": "D013390"}, {"text": "post-suxamethonium pains", "identifier": "D004961"}, {"text": "Nigerian", "identifier": "D004961"}, {"text": "scoline pain", "identifier": "D000072716"}, {"text": "Coxon", "identifier": "D004961"}, {"text": "prospective study", "identifier": "D011446"}, {"text": "total of 100 Nigerian patients", "identifier": "D014187"}, {"text": "out-patients", "identifier": "D010045"}, {"text": "in-patients", "identifier": "D004961"}, {"text": "fasciculations", "identifier": "D004961"}, {"text": "Fazadinium", "identifier": "D004961"}], [{"text": "albuterol", "identifier": "D000420"}, {"text": "severe exacerbations of asthma", "identifier": "D001249"}, {"text": "adults", "identifier": "D000328"}, {"text": "continuously nebulized albuterol (CNA)", "identifier": "D000420"}, {"text": "intermittent albuterol (INA)", "identifier": "D000420"}, {"text": "cardiac dysrhythmias", "identifier": "D024722"}, {"text": "hypokalemia", "identifier": "D007008"}, {"text": "heart rates", "identifier": "D005540"}, {"text": "intubation", "identifier": "D007440"}, {"text": "mortality", "identifier": "D007226"}], [{"text": "Renal-transplant", "identifier": "D004961"}, {"text": "proteinuria", "identifier": "D011507"}, {"text": "everolimus", "identifier": "D000068338"}, {"text": "mammalian target of rapamycin inhibitors", "identifier": "D000076225"}, {"text": "mTOR-i", "identifier": "D004961"}, {"text": "AL amyloidosis", "identifier": "D000075363"}, {"text": "monoclonal gammapathy", "identifier": "D010265"}, {"text": "undetermined significance", "identifier": "D008998"}, {"text": "histological evidence", "identifier": "D055317"}, {"text": "acute rejection", "identifier": "D006084"}], [{"text": "Epinephrine", "identifier": "D004837"}, {"text": "bupivacaine", "identifier": "D002045"}, {"text": "dysrhythmias", "identifier": "D004961"}, {"text": "epinephrine", "identifier": "D004837"}, {"text": "bupivacaine", "identifier": "D002045"}, {"text": "conscious dogs", "identifier": "D004285"}, {"text": "healthy dogs", "identifier": "D004285"}, {"text": "myocardial infarction", "identifier": "D056989"}, {"text": "anesthetized dogs", "identifier": "D004285"}, {"text": "ventricular tachycardia", "identifier": "D017180"}], [{"text": "N-substituted piperazine derivative", "identifier": "D034442"}, {"text": "trans-2-amino-3-hydroxy-1, 2, 3, 4-tetrahydroanaphthalene", "identifier": "D002893"}, {"text": "N-(trans-3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-N-(3-oxo-3-phenyl-2-methylpropyl)-piperazine hydrochloride", "identifier": "D000069439"}, {"text": "P11", "identifier": "D004961"}, {"text": "anaesthesized cats", "identifier": "D002415"}], [{"text": "Neuroleptic malignant syndrome", "identifier": "D009459"}, {"text": "risperidone", "identifier": "D018967"}, {"text": "levomepromazine", "identifier": "D008728"}, {"text": "chronic renal failure", "identifier": "D007676"}, {"text": "intestinal bleeding", "identifier": "D008796"}, {"text": "massive intestinal bleeding", "identifier": "D008796"}, {"text": "patient with CRF", "identifier": "D010358"}, {"text": "complication", "identifier": "D007431"}, {"text": "special caution", "identifier": "D006782"}], [{"text": "Hypercalcemia", "identifier": "D006934"}, {"text": "arrhythmia", "identifier": "D001146"}, {"text": "mood stabilizers", "identifier": "D007508"}, {"text": "lithium", "identifier": "D008094"}, {"text": "bipolar patient", "identifier": "D051245"}, {"text": "maintenance lithium therapy", "identifier": "D008094"}, {"text": "hypercalcemia", "identifier": "D006934"}, {"text": "severe bradyarrhythmia", "identifier": "D001919"}, {"text": "retrospective study", "identifier": "D012189"}, {"text": "bipolar patients", "identifier": "D051245"}], [{"text": "ibuprofen", "identifier": "D007052"}, {"text": "pulmonary hypertension", "identifier": "D006976"}, {"text": "very preterm infants", "identifier": "D007234"}, {"text": "patent ductus arteriosus", "identifier": "D004374"}, {"text": "prophylactic treatment", "identifier": "D000072036"}, {"text": "hypoxaemia", "identifier": "D004961"}, {"text": "echocardiography", "identifier": "D004452"}, {"text": "inhaled nitric oxide therapy", "identifier": "D020030"}, {"text": "preterm infants", "identifier": "D007234"}], [{"text": "contrast medium", "identifier": "D015350"}, {"text": "nephrotoxicity", "identifier": "D004961"}, {"text": "renal dysfunction", "identifier": "D000080343"}, {"text": "iodinated contrast medium", "identifier": "D006847"}, {"text": "renal angioplasty", "identifier": "D017130"}, {"text": "percutaneous coronary intervention", "identifier": "D062645"}, {"text": "creatinine", "identifier": "D003404"}, {"text": "patients", "identifier": "D010361"}, {"text": "interventional procedure", "identifier": "D015641"}, {"text": "benefit", "identifier": "D006264"}], [{"text": "aminoglycosides", "identifier": "D000617"}, {"text": "nephrotoxicity", "identifier": "D004961"}, {"text": "proximal tubular damage", "identifier": "D000141"}, {"text": "glomerular", "identifier": "D005920"}, {"text": "tubular dysfunction", "identifier": "D000141"}, {"text": "clinical trials", "identifier": "D064792"}, {"text": "seriously ill patients", "identifier": "D028642"}, {"text": "acute renal failure", "identifier": "D058186"}, {"text": "duration of therapy", "identifier": "D000081206"}, {"text": "plasma aminoglycoside levels", "identifier": "D010949"}], [{"text": "Amiodarone", "identifier": "D000638"}, {"text": "torsade de pointes", "identifier": "D016171"}, {"text": "oral amiodarone therapy", "identifier": "D005440"}, {"text": "hypokalemia", "identifier": "D007008"}, {"text": "digoxin excess", "identifier": "D043204"}, {"text": "bladder irrigation", "identifier": "D057914"}, {"text": "proarrhythmia", "identifier": "D004961"}, {"text": "bradycardia", "identifier": "D001919"}, {"text": "vagal maneuver", "identifier": "D014636"}, {"text": "amiodarone-induced proarrhythmia", "identifier": "D004961"}], [{"text": "nicotine", "identifier": "D009538"}, {"text": "seizures", "identifier": "D012640"}, {"text": "hippocampal nicotinic receptors", "identifier": "D011978"}, {"text": "alpha-bungarotoxin", "identifier": "D002038"}, {"text": "mice", "identifier": "D018345"}, {"text": "classical F2 and backcross genetic design", "identifier": "D005160"}, {"text": "alpha-bungarotoxin binding", "identifier": "D002038"}, {"text": "dithiothreitol", "identifier": "D004229"}, {"text": "trypsin", "identifier": "D014361"}, {"text": "heat", "identifier": "D006359"}], [{"text": "Chronic hyperprolactinemia", "identifier": "D006966"}, {"text": "prolactin", "identifier": "D011389"}, {"text": "TIDA system", "identifier": "D004064"}, {"text": "haloperidol", "identifier": "D006220"}, {"text": "dopamine", "identifier": "D011954"}, {"text": "median eminence", "identifier": "D008473"}, {"text": "norepinephrine", "identifier": "D009638"}, {"text": "serotonin", "identifier": "D020230"}, {"text": "5-hydroxyindoleacetic acid", "identifier": "D000156"}], [{"text": "Progesterone", "identifier": "D011980"}, {"text": "bupivacaine", "identifier": "D002045"}, {"text": "arrhythmogenicity", "identifier": "D004961"}, {"text": "pentobarbital", "identifier": "D010424"}, {"text": "rats", "identifier": "D011923"}, {"text": "anesthetized rats", "identifier": "D011923"}, {"text": "beating rat heart myocyte cultures", "identifier": "D047549"}, {"text": "AD50", "identifier": "D004961"}, {"text": "progesterone HCl", "identifier": "D011980"}, {"text": "estradiol", "identifier": "D011959"}, {"text": "epinephrine", "identifier": "D004837"}], [{"text": "Bepridil hydrochloride", "identifier": "D015764"}, {"text": "atrial fibrillation", "identifier": "D001281"}, {"text": "atrial flutter", "identifier": "D001282"}, {"text": "torsade de pointes", "identifier": "D016171"}, {"text": "left ventricular ejection fraction", "identifier": "D013318"}, {"text": "atrial dimension", "identifier": "D014716"}, {"text": "serum potassium concentration", "identifier": "D003209"}, {"text": "ECG", "identifier": "D004562"}, {"text": "hypokalemia", "identifier": "D007008"}, {"text": "heart rate", "identifier": "D006340"}], [{"text": "Rifampicin", "identifier": "D012293"}, {"text": "segmental necrotizing glomerulonephritis", "identifier": "D005923"}, {"text": "glomerulonephritis", "identifier": "D015432"}, {"text": "staphylococcal endocarditis", "identifier": "D004696"}, {"text": "acute renal failure", "identifier": "D058186"}, {"text": "tuberculosis", "identifier": "D018088"}, {"text": "IE", "identifier": "D004961"}, {"text": "Staphylococcal infections", "identifier": "D013207"}, {"text": "renal failure", "identifier": "D051437"}], [{"text": "methamphetamine", "identifier": "D008694"}, {"text": "psychosis", "identifier": "D001714"}, {"text": "methamphetamine-dependent patients", "identifier": "D010361"}, {"text": "risk", "identifier": "D012306"}, {"text": "DSM-IV", "identifier": "D039721"}, {"text": "teaching hospital", "identifier": "D012073"}, {"text": "drug rehabilitation center", "identifier": "D016320"}, {"text": "patients", "identifier": "D010361"}, {"text": "mini international neuropsychiatric interview", "identifier": "D011569"}], [{"text": "Niacin extended-release/lovastatin", "identifier": "D009525"}, {"text": "primary hypercholesterolemia", "identifier": "D006937"}, {"text": "mixed dyslipidemia", "identifier": "D050171"}, {"text": "Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT)", "identifier": "D010349"}, {"text": "niacin extended-release", "identifier": "D009525"}, {"text": "lovastatin", "identifier": "D008148"}, {"text": "dyslipidemia", "identifier": "D050171"}, {"text": "drug intervention", "identifier": "D000079382"}, {"text": "bedtime", "identifier": "D004961"}], [{"text": "5-Fluorouracil", "identifier": "D005472"}, {"text": "cardiotoxicity", "identifier": "D066126"}, {"text": "alpha-fluoro-beta-alanine", "identifier": "D004961"}, {"text": "FBAL", "identifier": "D004961"}, {"text": "5-FU", "identifier": "D005472"}, {"text": "malignancies", "identifier": "D019337"}, {"text": "unresectable colon cancer", "identifier": "D003110"}, {"text": "liver", "identifier": "D008930"}, {"text": "lung", "identifier": "D016040"}, {"text": "70-year-old man", "identifier": "D006801"}, {"text": "precordial pain", "identifier": "D002637"}], [{"text": "bortezomib", "identifier": "D000069286"}, {"text": "thalidomide", "identifier": "D013792"}, {"text": "dexamethasone", "identifier": "D003908"}, {"text": "VTD", "identifier": "D004961"}, {"text": "multiple myeloma", "identifier": "D000075122"}, {"text": "autologous stem cell transplantation", "identifier": "D033581"}, {"text": "consolidation therapy", "identifier": "D000069077"}, {"text": "bortezomib", "identifier": "D000069286"}, {"text": "thalidomide", "identifier": "D013792"}, {"text": "dexamethasone", "identifier": "D003908"}], [{"text": "Glyceryl trinitrate", "identifier": "D005995"}, {"text": "diclofenac", "identifier": "D004008"}, {"text": "primary dysmenorrhea", "identifier": "D004412"}, {"text": "prostaglandins", "identifier": "D011453"}, {"text": "nitric oxide", "identifier": "D020030"}, {"text": "NO", "identifier": "D013645"}, {"text": "hypersecretion", "identifier": "D006964"}, {"text": "endometrial", "identifier": "D004714"}, {"text": "uterine contractility", "identifier": "D014593"}, {"text": "non-steroidal anti-inflammatory drugs", "identifier": "D000894"}], [{"text": "Metallothionein", "identifier": "D008668"}, {"text": "ZnSO4", "identifier": "D004961"}, {"text": "carmustine", "identifier": "D002330"}, {"text": "hippocampus", "identifier": "D006624"}, {"text": "cognitive functions", "identifier": "D016013"}, {"text": "learning", "identifier": "D000077321"}, {"text": "short-term memory", "identifier": "D008570"}, {"text": "glutathione reductase", "identifier": "D005980"}, {"text": "reduced glutathione", "identifier": "D005978"}, {"text": "tumor necrosis factor-alpha", "identifier": "D014409"}], [{"text": "Chlorhexidine diphosphanilate", "identifier": "D002710"}, {"text": "topical agent", "identifier": "D000287"}, {"text": "burns", "identifier": "D002056"}, {"text": "antimicrobial agents", "identifier": "D000890"}, {"text": "chlorhexidine phosphanilate", "identifier": "D002710"}, {"text": "burn patients", "identifier": "D002053"}, {"text": "infection", "identifier": "D014946"}, {"text": "mortality", "identifier": "D007226"}, {"text": "clinical trials", "identifier": "D064792"}, {"text": "pain", "identifier": "D000072716"}, {"text": "analogue scale", "identifier": "D010147"}], [{"text": "Aspirin", "identifier": "D000068342"}, {"text": "coronary heart disease", "identifier": "D003327"}, {"text": "cerebrovascular disease", "identifier": "D020144"}, {"text": "US Preventive Services Task Force", "identifier": "D011314"}, {"text": "cardiovascular events", "identifier": "D002320"}, {"text": "myocardial infarctions", "identifier": "D020526"}, {"text": "strokes", "identifier": "D004961"}, {"text": "death", "identifier": "D003643"}, {"text": "coronary heart disease", "identifier": "D003327"}, {"text": "cerebrovascular disease", "identifier": "D020144"}], [{"text": "acute kidney injury", "identifier": "D058186"}, {"text": "hospitalized", "identifier": "D002673"}, {"text": "Intensive Care Unit", "identifier": "D003422"}, {"text": "mortality", "identifier": "D007226"}, {"text": "hospital length of stay", "identifier": "D007902"}, {"text": "costs", "identifier": "D017048"}, {"text": "standard operating procedures", "identifier": "D009873"}, {"text": "antibiotics", "identifier": "D000903"}, {"text": "nephrotoxic", "identifier": "D004961"}, {"text": "vancomycin", "identifier": "D020713"}], [{"text": "Carbetocin", "identifier": "D004961"}, {"text": "maximum tolerated dose (MTD)", "identifier": "D020714"}, {"text": "intramuscular", "identifier": "D007273"}, {"text": "vaginal delivery", "identifier": "D036861"}, {"text": "normal vaginal birth", "identifier": "D016064"}, {"text": "healthy women", "identifier": "D000070497"}, {"text": "singleton pregnancies", "identifier": "D011275"}, {"text": "term", "identifier": "D000069451"}, {"text": "continual reassessment method (CRM)", "identifier": "D016037"}, {"text": "adverse events", "identifier": "D000069586"}], [{"text": "anxiety", "identifier": "D001008"}, {"text": "postoperative", "identifier": "D011182"}, {"text": "droperidol", "identifier": "D004329"}, {"text": "patient-controlled analgesia", "identifier": "D016058"}, {"text": "diamorphine", "identifier": "D003932"}, {"text": "psychological disturbance", "identifier": "D011581"}, {"text": "dopaminergic antiemetics", "identifier": "D059290"}, {"text": "extrapyramidal side effects", "identifier": "D065606"}, {"text": "subtle manifestations", "identifier": "D012877"}, {"text": "overlooked", "identifier": "D004961"}], [{"text": "Methyldopa", "identifier": "D008750"}, {"text": "hemolytic anemia", "identifier": "D000743"}, {"text": "antihypertensive medication", "identifier": "D000959"}, {"text": "Aldomet", "identifier": "D008750"}, {"text": "trauma admission", "identifier": "D010343"}, {"text": "Coombs' test", "identifier": "D003298"}, {"text": "polyspecific anti-human globulin", "identifier": "D003601"}, {"text": "monospecific IgG reagents", "identifier": "D003432"}, {"text": "warm reacting autoantibody", "identifier": "D052096"}], [{"text": "Botulinum toxin", "identifier": "D001905"}, {"text": "Botox", "identifier": "D019274"}, {"text": "adductor spasmodic dysphonia", "identifier": "D055154"}, {"text": "ADSD", "identifier": "D004961"}, {"text": "breathiness", "identifier": "D004961"}, {"text": "throat pain", "identifier": "D010614"}, {"text": "difficulty swallowing", "identifier": "D051346"}, {"text": "botulinum toxin injections", "identifier": "D001905"}, {"text": "thyroarytenoid muscles", "identifier": "D007821"}], [{"text": "Gentamicin", "identifier": "D005839"}, {"text": "nephropathy", "identifier": "D001449"}, {"text": "Na/K-ATPase", "identifier": "D004961"}, {"text": "NHE3", "identifier": "D004961"}, {"text": "NBC1", "identifier": "D027982"}, {"text": "AQP1", "identifier": "D051398"}, {"text": "OAT", "identifier": "D018288"}, {"text": "creatinine clearance", "identifier": "D003404"}, {"text": "plasma creatinine", "identifier": "D003404"}, {"text": "fractional excretion of sodium", "identifier": "D005590"}], [{"text": "oxitropium bromide", "identifier": "D003488"}, {"text": "nocturnal asthma", "identifier": "D004418"}, {"text": "placebo-controlled", "identifier": "D004961"}, {"text": "double-blind study", "identifier": "D004311"}, {"text": "oxitropium bromide", "identifier": "D003488"}, {"text": "600 micrograms", "identifier": "D004961"}, {"text": "400 micrograms", "identifier": "D007654"}, {"text": "theophylline", "identifier": "D013806"}, {"text": "slow-release theophylline", "identifier": "D013806"}, {"text": "nocturnal asthma", "identifier": "D004418"}], [{"text": "Pethidine", "identifier": "D008614"}, {"text": "opioid", "identifier": "D000701"}, {"text": "opioid-receptors", "identifier": "D004961"}, {"text": "norpethidine", "identifier": "D004961"}, {"text": "nausea", "identifier": "D009325"}, {"text": "vomiting", "identifier": "D014839"}, {"text": "hypotension", "identifier": "D007023"}, {"text": "renal function", "identifier": "D012129"}, {"text": "liver function", "identifier": "D008111"}, {"text": "long-term pain control", "identifier": "D017774"}], [{"text": "Biperiden", "identifier": "D001712"}, {"text": "bradycardia", "identifier": "D001919"}, {"text": "38-year-old", "identifier": "D004961"}, {"text": "male", "identifier": "D007248"}, {"text": "severe postzosteric trigeminal neuralgia", "identifier": "D014277"}, {"text": "intravenous application", "identifier": "D007586"}, {"text": "10 mg biperiden lactate", "identifier": "D045022"}, {"text": "paradoxical reaction", "identifier": "D019320"}, {"text": "dysarthria", "identifier": "D004401"}, {"text": "dysphagia", "identifier": "D003680"}], [{"text": "Penicillamine", "identifier": "D010396"}, {"text": "lichenoid dermatitis", "identifier": "D017512"}, {"text": "Wilson's disease", "identifier": "D006527"}, {"text": "hepatic presentation", "identifier": "D007746"}, {"text": "anxiety", "identifier": "D001008"}, {"text": "SPECT", "identifier": "D000072098"}, {"text": "99mTc-ECD", "identifier": "D004961"}, {"text": "frontal lobes", "identifier": "D015522"}, {"text": "copper metabolism", "identifier": "D003300"}, {"text": "copper accumulation", "identifier": "D000067552"}], [{"text": "Histamine antagonists", "identifier": "D006633"}, {"text": "d-tubocurarine", "identifier": "D014403"}, {"text": "cardiac surgical patients", "identifier": "D006348"}, {"text": "hemodynamic effects", "identifier": "D000074743"}, {"text": "histamine", "identifier": "D006632"}, {"text": "H1-histamine antagonists", "identifier": "D018492"}, {"text": "H2-histamine antagonists", "identifier": "D018492"}, {"text": "cimetidine", "identifier": "D002927"}, {"text": "chlorpheniramine", "identifier": "D002744"}], [{"text": "lithium", "identifier": "D008094"}, {"text": "manic depression", "identifier": "D001714"}, {"text": "hyperosmolar nonketotic coma", "identifier": "D006944"}, {"text": "nephrogenic diabetes insipidus", "identifier": "D018500"}, {"text": "polyuria", "identifier": "D011141"}, {"text": "polydipsia", "identifier": "D059606"}, {"text": "hyperglycaemia", "identifier": "D004961"}, {"text": "normal blood glucose concentrations", "identifier": "D001786"}, {"text": "water deprivation testing", "identifier": "D014868"}, {"text": "type 2 diabetes", "identifier": "D003924"}], [{"text": "Exercise", "identifier": "D015444"}, {"text": "isoproterenol", "identifier": "D007545"}, {"text": "myocardial infarction", "identifier": "D056989"}, {"text": "male rats", "identifier": "D011923"}, {"text": "treadmill", "identifier": "D005080"}, {"text": "mortality", "identifier": "D007226"}, {"text": "CPK activity", "identifier": "D009043"}, {"text": "severity", "identifier": "D015599"}, {"text": "infarction", "identifier": "D007238"}, {"text": "lesions", "identifier": "D000070896"}, {"text": "heart weight", "identifier": "D015431"}], [{"text": "doxorubicin", "identifier": "D004317"}, {"text": "monohydroxyethylrutoside", "identifier": "D004961"}, {"text": "cardiotoxicity", "identifier": "D066126"}, {"text": "anthracyclin", "identifier": "D004961"}, {"text": "free radicals", "identifier": "D005609"}, {"text": "reactive oxygen species", "identifier": "D017382"}, {"text": "cardiac myocytes", "identifier": "D032383"}, {"text": "semisynthetic flavonoid", "identifier": "D014614"}, {"text": "monoHER", "identifier": "D004961"}, {"text": "BALB/c mice", "identifier": "D018345"}, {"text": "saline", "identifier": "D000077330"}], [{"text": "Levodopa", "identifier": "D007980"}, {"text": "Parkinson's disease", "identifier": "D010300"}, {"text": "HOMER1", "identifier": "D004961"}, {"text": "homer1", "identifier": "D004961"}, {"text": "glutamate transmission", "identifier": "D009435"}, {"text": "motor fluctuations", "identifier": "D009045"}, {"text": "dyskinesia", "identifier": "D004409"}, {"text": "visual hallucinations", "identifier": "D006212"}, {"text": "rs4704559", "identifier": "D004961"}, {"text": "rs10942891", "identifier": "D004961"}], [{"text": "Levobupivacaine", "identifier": "D000077554"}, {"text": "central nervous system", "identifier": "D016543"}, {"text": "toxicity", "identifier": "D018675"}, {"text": "local anesthetics", "identifier": "D000779"}, {"text": "grand mal seizures", "identifier": "D012640"}, {"text": "lumbar plexus block", "identifier": "D065527"}, {"text": "posterior approach", "identifier": "D000077002"}, {"text": "elective orthopedic surgery", "identifier": "D019637"}, {"text": "lower limb", "identifier": "D035002"}, {"text": "beta-adrenergic antagonist medications", "identifier": "D057985"}], [{"text": "hormones", "identifier": "D005768"}, {"text": "breast cancer", "identifier": "D000069584"}, {"text": "hormonal replacement therapy", "identifier": "D017582"}, {"text": "menopausal women", "identifier": "D014930"}, {"text": "surgical menopause", "identifier": "D008594"}, {"text": "mean age", "identifier": "D063847"}, {"text": "progestins", "identifier": "D045167"}, {"text": "estrogenic stimulation", "identifier": "D042782"}, {"text": "mammary", "identifier": "D042361"}, {"text": "endometrial", "identifier": "D004714"}], [{"text": "S-312-d", "identifier": "D004961"}, {"text": "S-312", "identifier": "D004961"}, {"text": "S-312-l", "identifier": "D004961"}, {"text": "dihydrothienopyridine", "identifier": "D004961"}, {"text": "calcium antagonist", "identifier": "D015220"}, {"text": "DBA/2 mice", "identifier": "D018345"}, {"text": "audiogenic tonic convulsions", "identifier": "D015845"}, {"text": "ED50", "identifier": "D004961"}, {"text": "p.o.", "identifier": "D042441"}, {"text": "flunarizine", "identifier": "D005444"}], [{"text": "Amiodarone", "identifier": "D000638"}, {"text": "myxoedema coma", "identifier": "D020207"}, {"text": "bradycardia", "identifier": "D001919"}, {"text": "hypothermia", "identifier": "D007035"}, {"text": "respiratory failure", "identifier": "D012131"}, {"text": "atrial fibrillation", "identifier": "D001281"}, {"text": "thyroid-stimulating hormone", "identifier": "D013972"}, {"text": "free thyroxine", "identifier": "D005608"}, {"text": "levothyroxine", "identifier": "D013974"}, {"text": "intensive care unit", "identifier": "D003422"}], [{"text": "propranolol", "identifier": "D011433"}, {"text": "B 24/76", "identifier": "D045303"}, {"text": "isoproterenol", "identifier": "D007545"}, {"text": "heart hypertrophy", "identifier": "D006332"}, {"text": "rat", "identifier": "D017941"}, {"text": "blood pressure", "identifier": "D001794"}, {"text": "ornithine decarboxylase", "identifier": "D009955"}, {"text": "myosin isoenzyme", "identifier": "D024461"}, {"text": "beta-receptor blocker", "identifier": "D015220"}, {"text": "beta 1-adrenoceptor", "identifier": "D001610"}], [{"text": "epirubicin", "identifier": "D015251"}, {"text": "non-Hodgkin lymphoma", "identifier": "D008228"}, {"text": "echocardiography", "identifier": "D004452"}, {"text": "speckle tracking echocardiography", "identifier": "D004452"}, {"text": "high-sensitive cardiac troponin T", "identifier": "D020107"}], [{"text": "Delirium", "identifier": "D003693"}, {"text": "fluoxetine", "identifier": "D005473"}, {"text": "selective serotonin reuptake inhibitors", "identifier": "D017367"}, {"text": "tricyclic antidepressants", "identifier": "D000929"}, {"text": "serum concentrations", "identifier": "D044967"}, {"text": "central nervous system side effects", "identifier": "D016543"}, {"text": "elderly patients", "identifier": "D016330"}, {"text": "citalopram", "identifier": "D015283"}, {"text": "somnolence", "identifier": "D000077260"}, {"text": "movement difficulties", "identifier": "D009068"}], [{"text": "Syndrome of inappropriate secretion of antidiuretic hormone", "identifier": "D007177"}, {"text": "vincristine", "identifier": "D014750"}, {"text": "antidiuretic hormone", "identifier": "D065092"}, {"text": "hyponatremia", "identifier": "D007010"}, {"text": "multiple myeloma", "identifier": "D000075122"}, {"text": "refractory", "identifier": "D012033"}, {"text": "doxorubicin", "identifier": "D004317"}, {"text": "dexamethasone", "identifier": "D003908"}, {"text": "intravenous infusion", "identifier": "D007260"}], [{"text": "acute renal failure", "identifier": "D058186"}, {"text": "prolonged intake", "identifier": "D002149"}, {"text": "slimming pills", "identifier": "D000068776"}, {"text": "anthraquinones", "identifier": "D000880"}, {"text": "Rhizoma Rhei", "identifier": "D030021"}, {"text": "rhubarb", "identifier": "D012250"}, {"text": "anthraquinone derivatives", "identifier": "D000880"}, {"text": "nephropathy", "identifier": "D001449"}, {"text": "Chinese herbal medicine", "identifier": "D004365"}, {"text": "phytotherapy", "identifier": "D008517"}], [{"text": "5-fluorouracil", "identifier": "D005472"}, {"text": "transient hyperammonemic encephalopathy", "identifier": "D000070627"}, {"text": "cancer patients", "identifier": "D010361"}, {"text": "dehydration", "identifier": "D003681"}, {"text": "infection", "identifier": "D014946"}, {"text": "5-fluorouracil", "identifier": "D005472"}, {"text": "hyperammonemic encephalopathy", "identifier": "D000070627"}, {"text": "plasma ammonium", "identifier": "D064751"}, {"text": "azotemia", "identifier": "D053099"}], [{"text": "17alpha-ethinylestradiol", "identifier": "D004961"}, {"text": "bile salt", "identifier": "D001654"}, {"text": "neutral pathway", "identifier": "D020383"}, {"text": "acidic pathway", "identifier": "D020384"}, {"text": "17alpha-ethinylestradiol", "identifier": "D004961"}, {"text": "intact enterohepatic circulation", "identifier": "D004764"}, {"text": "long-term bile diversion", "identifier": "D064422"}, {"text": "bile salt pool composition", "identifier": "D005788"}, {"text": "cholate", "identifier": "D020358"}, {"text": "chenodeoxycholate", "identifier": "D002635"}], [{"text": "Convulsion", "identifier": "D003294"}, {"text": "intravenous fluorescein", "identifier": "D007275"}, {"text": "fundus angiography", "identifier": "D005451"}, {"text": "tonic-clonic seizures", "identifier": "D012640"}, {"text": "fluorescein", "identifier": "D005451"}, {"text": "adverse reaction", "identifier": "D016907"}, {"text": "re-exposure", "identifier": "D004961"}], [{"text": "Human corticotropin-releasing hormone (hCRH)", "identifier": "D003346"}, {"text": "Thyrotropin-releasing hormone (TRH)", "identifier": "D013973"}, {"text": "ventilation", "identifier": "D014691"}, {"text": "humans", "identifier": "D006801"}, {"text": "placebo-controlled", "identifier": "D004961"}, {"text": "single-blind study", "identifier": "D016037"}, {"text": "CO2-rebreathing tests", "identifier": "D015197"}, {"text": "0.9% NaCl", "identifier": "D000077330"}], [{"text": "1,3-Butadiene", "identifier": "D004961"}, {"text": "chronic myeloid leukemia", "identifier": "D015466"}, {"text": "CML", "identifier": "D004961"}, {"text": "ionizing radiation", "identifier": "D011839"}, {"text": "Philadelphia chromosome", "identifier": "D010677"}, {"text": "translocation", "identifier": "D014178"}, {"text": "human myeloid cell line", "identifier": "D000078722"}, {"text": "positive control", "identifier": "D000080032"}], [{"text": "Hyponatremia", "identifier": "D007010"}, {"text": "syndrome of inappropriate secretion of anti-diuretic hormone (SIADH)", "identifier": "D007177"}, {"text": "Vincristine", "identifier": "D014750"}, {"text": "leukemia", "identifier": "D007951"}, {"text": "lymphoma", "identifier": "D016483"}, {"text": "Asians", "identifier": "D044466"}, {"text": "hyponatremia and/or SIADH", "identifier": "D007010"}, {"text": "reporting rate", "identifier": "D019221"}, {"text": "treated patients", "identifier": "D010361"}], [{"text": "Neurocognitive", "identifier": "D019965"}, {"text": "neuroradiologic", "identifier": "D004961"}, {"text": "central nervous system", "identifier": "D016543"}, {"text": "children", "identifier": "D019988"}, {"text": "Pediatric Oncology Group", "identifier": "D008495"}, {"text": "P9605", "identifier": "D004961"}, {"text": "P9201", "identifier": "D004961"}, {"text": "acute lymphoblastic leukemia", "identifier": "D054198"}, {"text": "standard risk", "identifier": "D012306"}, {"text": "intensive consolidation", "identifier": "D000069077"}, {"text": "intrathecal", "identifier": "D007278"}], [{"text": "Crocin", "identifier": "D004961"}, {"text": "diazinon", "identifier": "D003976"}, {"text": "organophosphorus insecticides", "identifier": "D007306"}, {"text": "lipid metabolism", "identifier": "D050356"}, {"text": "cholesterol", "identifier": "D008076"}, {"text": "triglyceride", "identifier": "D000012"}, {"text": "LDL", "identifier": "D051131"}, {"text": "low-density lipoprotein receptor", "identifier": "D008077"}, {"text": "Extracellular signal-regulated kinase", "identifier": "D048049"}, {"text": "ERK", "identifier": "D048049"}], [{"text": "olanzapine", "identifier": "D000077152"}, {"text": "acute bipolar mania", "identifier": "D001714"}, {"text": "DSM-IV", "identifier": "D039721"}, {"text": "Young-Mania Rating Scale (Y-MRS)", "identifier": "D000067290"}, {"text": "Olanzipine HGGW Study Group", "identifier": "D065386"}, {"text": "bipolar disorder", "identifier": "D001714"}, {"text": "manic", "identifier": "D001714"}, {"text": "mixed", "identifier": "D007959"}, {"text": "DSM-IV diagnosis", "identifier": "D011296"}, {"text": "randomized", "identifier": "D016032"}], [{"text": "Levetiracetam", "identifier": "D000077287"}, {"text": "phenobarbital", "identifier": "D010634"}, {"text": "cats", "identifier": "D002415"}, {"text": "epilepsy", "identifier": "D020195"}, {"text": "idiopathic epilepsy", "identifier": "D004831"}, {"text": "pharmacokinetics", "identifier": "D010599"}, {"text": "efficacy", "identifier": "D020377"}, {"text": "tolerability", "identifier": "D004961"}, {"text": "seizure frequency", "identifier": "D005787"}, {"text": "seizures", "identifier": "D012640"}], [{"text": "trazodone", "identifier": "D014196"}, {"text": "5-hydroxytryptamine", "identifier": "D044405"}, {"text": "5-HT", "identifier": "D011985"}, {"text": "5-HT 2A receptors", "identifier": "D044402"}, {"text": "5-HT 2C receptors", "identifier": "D044405"}, {"text": "dopaminergic neurotransmission", "identifier": "D059290"}, {"text": "dexamphetamine", "identifier": "D003913"}, {"text": "apomorphine", "identifier": "D001058"}, {"text": "haloperidol", "identifier": "D006220"}, {"text": "ergometrine", "identifier": "D004874"}], [{"text": "Asterixis", "identifier": "D020820"}, {"text": "carbamazepine", "identifier": "D002220"}, {"text": "psychopharmacologic agents", "identifier": "D000890"}, {"text": "neurotoxicity", "identifier": "D020258"}, {"text": "lithium", "identifier": "D008094"}, {"text": "clozapine", "identifier": "D003024"}, {"text": "CBZ", "identifier": "D004961"}, {"text": "psychotropic drugs", "identifier": "D011619"}, {"text": "combination therapy", "identifier": "D004359"}, {"text": "dosage", "identifier": "D011879"}], [{"text": "Non-steroidal anti-inflammatory drugs (NSAIDs)", "identifier": "D000894"}, {"text": "acute interstitial nephritis (ATIN)", "identifier": "D009395"}, {"text": "acute renal failure", "identifier": "D058186"}, {"text": "immune complex-mediated tubulo-interstitial injury", "identifier": "D015427"}, {"text": "aspirin", "identifier": "D000068342"}, {"text": "ibuprofen", "identifier": "D007052"}, {"text": "aortic valve surgery", "identifier": "D001021"}, {"text": "blood urea nitrogen (BUN)", "identifier": "D001806"}, {"text": "creatinine", "identifier": "D003404"}], [{"text": "Fluoxetine", "identifier": "D005473"}, {"text": "5-fluorouracil", "identifier": "D005472"}, {"text": "chemotherapy", "identifier": "D060828"}, {"text": "5-FU", "identifier": "D005472"}, {"text": "cancer patients", "identifier": "D010361"}, {"text": "systemic adjuvant chemotherapy", "identifier": "D017024"}, {"text": "blood-brain barrier", "identifier": "D001812"}, {"text": "neurogenesis", "identifier": "D055495"}, {"text": "adult brain", "identifier": "D032721"}, {"text": "hippocampal dependent neurogenesis", "identifier": "D055495"}], [{"text": "Pilsicainide", "identifier": "D004961"}, {"text": "sudden cardiac death", "identifier": "D016757"}, {"text": "torsades de pointes", "identifier": "D016171"}, {"text": "paroxysmal atrial fibrillation", "identifier": "D001281"}, {"text": "sinus rhythm", "identifier": "D002940"}, {"text": "Holter electrocardiogram", "identifier": "D015716"}, {"text": "gastrointestinal tract", "identifier": "D041981"}, {"text": "renal function", "identifier": "D012129"}, {"text": "plasma concentration", "identifier": "D003209"}, {"text": "class IC drugs", "identifier": "D013287"}], [{"text": "Branch retinal vein occlusion", "identifier": "D012170"}, {"text": "fluoxetine", "identifier": "D005473"}, {"text": "selective serotonin reuptake inhibitor", "identifier": "D017367"}, {"text": "hypertension", "identifier": "D000075222"}, {"text": "ophthalmologists", "identifier": "D000072163"}, {"text": "secondary hypertension", "identifier": "D000075222"}, {"text": "fluoxetine-induced hypertension", "identifier": "D000075222"}, {"text": "branch retinal vein occlusion", "identifier": "D012170"}, {"text": "fluoxetine", "identifier": "D005473"}, {"text": "ophthalmology", "identifier": "D009885"}], [{"text": "Amiodarone", "identifier": "D000638"}, {"text": "anti-arrhythmic drug", "identifier": "D004342"}, {"text": "valvular heart disease", "identifier": "D006349"}, {"text": "lung mass", "identifier": "D013058"}, {"text": "proteinuria", "identifier": "D011507"}, {"text": "CT", "identifier": "D000072098"}, {"text": "positron emission tomography", "identifier": "D000072078"}, {"text": "lymphoplasmacytic infiltrates", "identifier": "D004961"}, {"text": "foamy macrophages", "identifier": "D008264"}, {"text": "myelinoid bodies", "identifier": "D008326"}], [{"text": "vincristine sulfate", "identifier": "D014750"}, {"text": "Pseudomonas aeruginosa", "identifier": "D011550"}, {"text": "rhesus monkeys", "identifier": "D008253"}, {"text": "acute illness", "identifier": "D002388"}, {"text": "spontaneous recovery", "identifier": "D011997"}, {"text": "leukocytosis", "identifier": "D007964"}, {"text": "blood cultures", "identifier": "D061245"}, {"text": "leukopenia", "identifier": "D007970"}, {"text": "pyocin type 6 Pseudomonas", "identifier": "D011709"}, {"text": "severe Pseudomonas sepsis", "identifier": "D018805"}], [{"text": "remoxipride", "identifier": "D017330"}, {"text": "apoptosis", "identifier": "D017209"}, {"text": "HL60", "identifier": "D018922"}, {"text": "CD34+/CD19-", "identifier": "D004961"}, {"text": "human bone marrow progenitor cells", "identifier": "D001854"}, {"text": "acquired aplastic anemia", "identifier": "D000741"}, {"text": "NCQ436", "identifier": "D004961"}, {"text": "NCQ344", "identifier": "D004961"}, {"text": "NCR181", "identifier": "D004961"}, {"text": "FLA873", "identifier": "D004961"}, {"text": "FLA797", "identifier": "D004961"}], [{"text": "ACC-9653", "identifier": "D004961"}, {"text": "phenytoin", "identifier": "D010672"}, {"text": "prodrug", "identifier": "D004961"}, {"text": "3-hydroxymethyl-5,5-diphenylhydantoin", "identifier": "D004961"}, {"text": "anticonvulsant", "identifier": "D000927"}, {"text": "seizures", "identifier": "D012640"}, {"text": "maximal electroshock", "identifier": "D004597"}, {"text": "mice", "identifier": "D018345"}, {"text": "oral", "identifier": "D003945"}, {"text": "i.v.", "identifier": "D009529"}], [{"text": "Cisplatin", "identifier": "D002945"}, {"text": "acute kidney injury", "identifier": "D058186"}, {"text": "renal function", "identifier": "D012129"}, {"text": "creatinine", "identifier": "D003404"}, {"text": "urea", "identifier": "D014508"}, {"text": "acute tubular necrosis", "identifier": "D007683"}, {"text": "IL-1b", "identifier": "D004961"}, {"text": "TNF-a", "identifier": "D000079424"}, {"text": "kinin B2 receptor", "identifier": "D065094"}, {"text": "deletion", "identifier": "D017384"}], [{"text": "adrenaline", "identifier": "D004837"}, {"text": "noradrenaline", "identifier": "D000068760"}, {"text": "hypertension", "identifier": "D000075222"}, {"text": "adrenaline-hypertension hypothesis", "identifier": "D061148"}, {"text": "double blind", "identifier": "D034723"}, {"text": "crossover study", "identifier": "D018592"}, {"text": "healthy volunteers", "identifier": "D064368"}, {"text": "infusions", "identifier": "D007263"}, {"text": "haemodynamic effects", "identifier": "D011830"}, {"text": "arterial pressure", "identifier": "D062186"}, {"text": "systolic arterial pressure", "identifier": "D062186"}], [{"text": "haloperidol", "identifier": "D006220"}, {"text": "cocaine", "identifier": "D003042"}, {"text": "amphetamine", "identifier": "D019969"}, {"text": "intoxication", "identifier": "D000435"}, {"text": "amphetamine", "identifier": "D019969"}, {"text": "cocaine", "identifier": "D003042"}, {"text": "seizures", "identifier": "D012640"}, {"text": "high doses", "identifier": "D016534"}, {"text": "mortality rate", "identifier": "D009026"}, {"text": "statistical significance", "identifier": "D003627"}, {"text": "central dopamine blocker", "identifier": "D011954"}], [{"text": "Vasoactive intestinal polypeptide (VIP)", "identifier": "D014660"}, {"text": "heart failure", "identifier": "D006333"}, {"text": "cobalt cardiomyopathy", "identifier": "D003035"}, {"text": "doxorubicin", "identifier": "D004317"}, {"text": "ventricular muscle", "identifier": "D018879"}, {"text": "left ventricular muscle", "identifier": "D017379"}, {"text": "papillary muscles", "identifier": "D010210"}, {"text": "rheumatic disease", "identifier": "D012214"}, {"text": "myxomatous degeneration", "identifier": "D009410"}], [{"text": "Cocaine", "identifier": "D003042"}, {"text": "ethanol", "identifier": "D000431"}, {"text": "cocaethylene", "identifier": "D004961"}, {"text": "cardiotoxicity", "identifier": "D066126"}, {"text": "cocaine", "identifier": "D003042"}, {"text": "ethanol", "identifier": "D000431"}, {"text": "cocaethylene", "identifier": "D004961"}, {"text": "animal model", "identifier": "D007942"}, {"text": "abuse", "identifier": "D013179"}, {"text": "cardiovascular collapse", "identifier": "D003096"}, {"text": "hemodynamic changes", "identifier": "D000074743"}], [{"text": "D-Glucarates", "identifier": "D004961"}, {"text": "renal damage", "identifier": "D001925"}, {"text": "aminoglycoside antibiotics", "identifier": "D000903"}, {"text": "dextran", "identifier": "D003911"}, {"text": "kanamycin", "identifier": "D007612"}, {"text": "peptide antibiotics", "identifier": "D000903"}, {"text": "renal failure", "identifier": "D051437"}, {"text": "2,5-di-O-acetyl-D-glucaro-1,4-6,3-dilactone", "identifier": "D004961"}, {"text": "saccharic acid", "identifier": "D005937"}], [{"text": "Flecainide", "identifier": "D005424"}, {"text": "delirium", "identifier": "D003693"}, {"text": "paroxetine", "identifier": "D017374"}, {"text": "pharmacokinetic drug interaction", "identifier": "D059647"}, {"text": "carvedilol", "identifier": "D000077261"}, {"text": "warfarin", "identifier": "D014859"}, {"text": "folic acid", "identifier": "D005494"}, {"text": "levothyroxine", "identifier": "D013974"}, {"text": "pantoprazole", "identifier": "D000077402"}, {"text": "atrial fibrillation", "identifier": "D001281"}], [{"text": "phase 2 early afterdepolarization (EAD)", "identifier": "D016195"}, {"text": "polymorphic ventricular tachycardia", "identifier": "D017180"}, {"text": "torsade de pointes (TdP)", "identifier": "D016171"}, {"text": "long-QT syndrome", "identifier": "D017562"}, {"text": "dl-sotalol", "identifier": "D004961"}, {"text": "azimilide", "identifier": "D004961"}, {"text": "transmural dispersion of repolarization (TDR)", "identifier": "D009905"}, {"text": "QT prolongation", "identifier": "D008133"}, {"text": "transmembrane action potentials", "identifier": "D000200"}], [{"text": "tacrolimus", "identifier": "D016559"}, {"text": "FK506", "identifier": "D022021"}, {"text": "bilateral optic neuropathy", "identifier": "D018917"}, {"text": "patient", "identifier": "D010358"}, {"text": "liver transplantation", "identifier": "D016031"}, {"text": "orthotropic liver transplantation", "identifier": "D016031"}, {"text": "neuro-ophthalmologic examinations", "identifier": "D011291"}, {"text": "laboratory studies", "identifier": "D059232"}, {"text": "ischemic optic neuropathies", "identifier": "D018917"}], [{"text": "Tranexamic acid", "identifier": "D014148"}, {"text": "overdosage", "identifier": "D004961"}, {"text": "generalized seizure", "identifier": "D004829"}, {"text": "renal failure", "identifier": "D051437"}, {"text": "chronic kidney disease", "identifier": "D007676"}, {"text": "chronic tubulointerstitial disease", "identifier": "D000079662"}, {"text": "hemorrhagia", "identifier": "D004961"}, {"text": "menorrhagia", "identifier": "D008595"}, {"text": "packed cells", "identifier": "D006400"}, {"text": "hemodialysis", "identifier": "D015312"}]]}
